CD274 and neoplasm: A group of tumors has the T cell-inflamed tumor phenotype, which is characterized by a large number of tumor-infiltrating lymphocytes (TILs) and interferon (IFN)-transcriptional profiles, including the expression of PD-L1 [53,54], and a high mutation burden responding to checkpoint immunotherapy [55].